Escalating Prevalence of IBD and Functional Disorders: Analyzing Gastrointestinal Drugs Market growth Drivers
  The trajectory of Gastrointestinal Drugs Market growth is fundamentally powered by the rapidly escalating global burden of chronic and functional gastrointestinal diseases. The increasing incidence and prevalence of Inflammatory Bowel Disease (IBD), particularly in newly industrialized nations (where Western lifestyles are adopted), is the single most powerful driver. IBD requires...
0 Comentários 0 Compartilhamentos 0 Anterior